Pediatric and newborn stroke

Current Treatment Options in Neurology

Volumn 10, Issue 6, 2008, Pages 431-439

  Goodman, Sharon ^a   Pavlakis, Steven ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 7; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

APNEA; BLOOD DISEASE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHILDHOOD MORTALITY; CLINICAL FEATURE; COIL EMBOLIZATION; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL HEART DISEASE; CONSCIOUSNESS DISORDER; CRANIECTOMY; DISEASE CLASSIFICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXCHANGE BLOOD TRANSFUSION; GENETIC ASSOCIATION; HEART SURGERY; HUMAN; HYPERTENSION; MOYAMOYA DISEASE; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NEWBORN; NEWBORN INFECTION; OCCLUSIVE CEREBROVASCULAR DISEASE; RADIOSURGERY; RECURRENT DISEASE; REVASCULARIZATION; REVIEW; SEIZURE; SICKLE CELL ANEMIA; VASCULAR DISEASE;

EID: 58649114027     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0045-6     Document Type: Review

References (50)

1. Lynch JK, HaW CJ: Pediatric stroke: what do we know and what do we need to know? Semin Neurol 2005, 25:410-423.
2. Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 51:169-176.
3. Giroud M, Lemesle M, Gouyon JB, et al.: Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: A study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995, 48:1343-1348.
4. Lynch JK, Pavlakis S, deVeber G: Treatment and prevention of cerebrovascular disorders in children. Curr Treat Options Neurol 2005, 7:469-480.
5. Seidman C, KCrkham F, Pavlakis S: Pediatric stroke: current developments. Cur Opin Pediatr 2007, 19:657-662.
6. Laugesaar R, Kolk A, Tomberg T, et al.: Acutely and retrospectively diagnosed perinatal stroke: A population-based study. Stroke 2007, 38:2234-2240.
7. Lo W, Zamel K, Ponnappa K, et al.: The cost of pediatric stroke care and rehabilitation. Stroke 2008, 39:161-165.
8. Fullerton HJ, Wu YW, Zhao S, Johnston SC: Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189-194.
9. Kupferman JC, Singh A, Pavlakis SG: Lacunar stroke and masked hypertension in an adolescent male. Pediatr Neurol 2007, 36:125-127.
10. Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167-173.
11. Monagle P, Chan A, Massicotte P, et al.: Antithrombotic therapy in children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:645S-687S.
12. Paediatric Stroke Working Group: Stroke in Childhood: Clinical Guidelines for Diagnosis, Management and Rehabilitation. London: Royal College of Physicians; 2004. Available at http://www.rcplondon.ac.uk/ pubs/books/childstroke/childstroke_guidelines.pdf.
13. Braun KP, Rafay MF, Uiterwaal CS, et al.: Mode of onset predicts etiological diagnosis of arterial ischemic stroke in children. Stroke 2007, 38:298-302.
14. Shellhaas RA, Smith SE, O'Tool E, et al.: Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics 2006, 118:704-709.
15. Gabis LV, Yangala R, Lenn NJ: Time lag to diagnosis of stroke in children. Pediatrics 2002, 110:924-928.
16. Kirkham FJ, Prengler M, Hewes DK, Ganesan V: Risk factors for arterial ischemic stroke in children. J Child Neurol 2000, 15:299-307.
17. Maguire J, deVeber G, Parkin PC: Association between iron deficiency anemia and stroke in young children. Pediatrics 2007, 120:1053-1057.
18. Strater R, Becker S, von Eckardstein A, et al.: Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002, 360:1540-1545.
19. Chan AK, deVeber G: Prothrombotic disorders and ischemic stroke in children. Semin Pediatr Neurol 2000, 7:301-308.
20. Voetsch B, Jin RC, Bierl C, et al.: Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke 2008, 39:303-307.
21. Reuner K, Jenetzky E, Lichy C, et al.: Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology 2008, 70: 129-132.
22. Voetsch B, Jin RC, Bierl C: Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: A novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007, 38:41-49.
23. deVeber G, Canadian Ischemic Stroke Study Group: Canadian Pediatric Stroke Registry: Analysis of children with arterial ischemic stroke [abstract]. Ann Neurol 2000, 48:526.
24. Mahle WT, Tavani F, Zimmerman RA, et al.: An MRI study of neurological injury before and after congenital heart surgery. Circulation 2002, 106(12 Suppl 1):I109-I114.
25. Scothorn DJ, Price C, Schwartz D, et al.: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348-354.
26. Pegelow CH, Macklin EA, Moser FG, et al.: Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002, 99:3014-3018.
27. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH: Sickle cell disease. Hematology Am Soc Hematol Educ Program 2004, 35-47.
28. Kirkham FJ, Lerner NB, Noetzel M, et al.: Trials in sickle cell disease. Pediatr Neurol 2006, 34:450-458.
29. Danchaivijitr N, Cox TC, Saunders DE, Ganesan V: Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann Neurol 2006, 59:620-626.
30. Sebire G, Fullerton H, Riou E, deVeber G: Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004, 16:617-622.
31. Fullerton HJ, Wu YW, Sidney S, Johnston SC: Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: The importance of cerebrovascular imaging. Pediatrics 2007, 119:495-501.
32. Fullerton HJ, Johnston SC, Smith WS: Arterial dissection and stroke in children. Neurology 2001, 57:1155-1160.
33. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: Results of multicenter survey in Japan. Stroke 2007, 38:1430-1435.
34. Mineharu Y, Takenaka K, Yamakawa H, et al.: Inheritance pattern of familial moyamoya disease: Autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006, 77: 1025-1029.
35. Ikeda H, Sasaki T, Yoshimoto T, et al.: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999, 64: 533-537.
36. Horn P, Pfister S, Bueltmann E, et al.: Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst 2004, 20: 382-391.
37. Czartoski T, Hallam D, Lacy JM, et al.: Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005, 76: 256-259.
38. Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: A case-control study. Ann Neurol 1999, 45:679-680.
39. Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: A study of frequency and causation. Stroke 2001, 32:1257-1262.
40. Miravet E, Danchaivitjitr N, Basu H: Clinical and radiological features of childhood infarction following varicella zoster virus infection. Dev Med Child Neurol 2007, 49: 417-422.
41. Di Rocco C, Tamburrini G, Rollo M: Cerebral arteriovenous malformations in children. Acta Neurochir (Wien) 2000, 142:145-156.
42. Smith ER, Butler WE, Ogilvy CS: Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol 2002, 15:165-171.
43. Chabrier S, HusOon B, Lasjaunias P, et al.: Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000, 15:290-294.
44. Max JE, Robin DA, Taylor HG, et al.: Attention function after childhood stroke. J Int Neuropsychol Soc 2004, 10:976-986.
45. Bernard TJ, Goldenberg NA, Armstrong-Wells J, et al.: Treatment of childhood arterial ischemic stroke. Ann Neurol 2008, 63:679-696.
46. Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
47. Clinical Alert from the National Heart, Lung, and Blood Institute. Bethesda, MD: National Heart, Lung, and Blood Institute; December 5, 2004. Available at http://www.nhlbi.nih.gov/health/prof/blood/sickle/ clinical-alert-scd.htm.
48. Clancy RR, McGaurn SA, Goin JE, et al.: Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001, 108:61-70.
49. Fung LW, Thompson D, Ganesan V: Revascularisation surgery for paediatric moyamoya: A review of the literature. Childs Nerv Syst 2005, 21:358-364.
50. Strater R, Kurnik K, Heller C, et al.: Aspirin versus low-dose low-molecular-weight heparin: Antithrombotic therapy in pediatric ischemic stroke patients: A prospective follow-up study. Stroke 2001, 32:2554-2558.